Evidence map›Paper›PMID 27834582›Full record

ArticleCell adhesion & migration2017

Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.

Valentina Bizzarro, Raffaella Belvedere, Vincenzo Migliaro, Elena Romano, Luca Parente, Antonello Petrella

Abstract read
In one paragraph

Article in Cell adhesion & migration, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Targeting theBiomedicines · 2025
    Article
  3. Article
  4. Article
  5. Exosome-derived ANXA9 functions as an oncogene in breast cancer.The journal of pathology. Clinical research · 2023
    Article
  6. Review
  7. Frontiers in microbiology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Valentina Bizzarroa Department of Pharmacy , University of Salerno , Fisciano (SA) , Italy.ORCID 0000-0002-5222-0705
Raffaella Belvederea Department of Pharmacy , University of Salerno , Fisciano (SA) , Italy.
Vincenzo Migliaroa Department of Pharmacy , University of Salerno , Fisciano (SA) , Italy.
Elena Romanoa Department of Pharmacy , University of Salerno , Fisciano (SA) , Italy.
Luca Parentea Department of Pharmacy , University of Salerno , Fisciano (SA) , Italy.
Antonello Petrellaa Department of Pharmacy , University of Salerno , Fisciano (SA) , Italy.ORCID 0000-0002-6945-5295

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Annexin A1 (ANXA1) is a Ca

Indexed as

Annexin A1Antigens, CDCadherinsCell HypoxiaCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansKeratin-18Keratin-8MaleNeoplasm InvasivenessProstateAnnexin A1Antigens, CDCadherinsCDH1 protein, humanKeratin-18Keratin-8RNA, Small Interferingannexin A1cell invasionepithelial to mesenchymal transitionERM complexhypoxiaintermediate filaments

Identifiers

PMID27834582
PMCPMC5479448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.